Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Adenoviridae Infections × fludarabine × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Leukemia, Myeloid, Acute 214 Precursor Cell Lymphoblastic Leukemia-Lymphoma 129 Myelodysplastic Syndromes 126 Leukemia, Lymphocytic, Chronic, B-Cell 126 Leukemia 114 Multiple Myeloma 107 Lymphoma 106 Lymphoma, Non-Hodgkin 104 Hematologic Neoplasms 69 Recurrence 66 Melanoma 64 Leukemia, Myelogenous, Chronic, BCR-ABL Positive 64 Hodgkin Disease 64 Lymphoma, B-Cell 56 Lymphoma, Mantle-Cell 48 Lymphoma, Follicular 48 Lymphoma, Large B-Cell, Diffuse 46 Myeloproliferative Disorders 39 Burkitt Lymphoma 38 Ovarian Neoplasms 36 Neoplasms 35 Neoplasm Metastasis 28 Lymphoma, B-Cell, Marginal Zone 28 Graft vs Host Disease 26 Leukemia, Biphenotypic, Acute 25 Breast Neoplasms 25 Carcinoma, Non-Small-Cell Lung 24 Primary Myelofibrosis 23 Neoplasms, Plasma Cell 23 Pancreatic Neoplasms 20

Interventions

Gemcitabine 2 Cell Count 2 ziprasidone 1 valrubicin 1 tretazicar 1 pembrolizumab 1 liposomal doxorubicin 1 fludarabine phosphate 1 fludarabine 1 enadenotucirev 1 atezolizumab 1 Zolpidem 1 Warfarin 1 Vecuronium Bromide 1 Vancomycin 1 Vaccines 1 Tumor Necrosis Factor-alpha 1 Tranexamic Acid 1 Tobramycin 1 Spironolactone 1 Sevelamer 1 Rocuronium 1 Radiotherapy 1 Piperacillin, Tazobactam Drug Combination 1 Pentobarbital 1 Oxycodone 1 Oncolytic Virotherapy 1 Nifedipine 1 Nafcillin 1 Molindone 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00625430 2011-07-11

FP253-GDEPT

Biotech Equity Partners Pty Ltd

Phase 1 Unknown

Adenoviridae Infections, Prostatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡